Home

Credenza Compagno fulmine gamma secretase inhibitor clinical trial fisico Somiglianza svegliati

γ-Secretase inhibitors repress thymocyte development | PNAS
γ-Secretase inhibitors repress thymocyte development | PNAS

γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and  functionally distinct | EMBO Molecular Medicine
γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct | EMBO Molecular Medicine

Semagacestat Is a Pseudo-Inhibitor of γ-Secretase - ScienceDirect
Semagacestat Is a Pseudo-Inhibitor of γ-Secretase - ScienceDirect

Turning the tide on Alzheimer's disease: modulation of γ-secretase | Cell &  Bioscience | Full Text
Turning the tide on Alzheimer's disease: modulation of γ-secretase | Cell & Bioscience | Full Text

Semagacestat – Gamma Secretase Inhibitor for Alzheimer's Disease - Clinical  Trials Arena
Semagacestat – Gamma Secretase Inhibitor for Alzheimer's Disease - Clinical Trials Arena

Alzheimer's disease-associated mutations increase amyloid precursor protein  resistance to γ-secretase cleavage and the Aβ42/Aβ40 ratio | Cell Discovery
Alzheimer's disease-associated mutations increase amyloid precursor protein resistance to γ-secretase cleavage and the Aβ42/Aβ40 ratio | Cell Discovery

Pharmaceuticals | Free Full-Text | BACE-1 and γ-Secretase as Therapeutic  Targets for Alzheimer's Disease | HTML
Pharmaceuticals | Free Full-Text | BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer's Disease | HTML

Targeting gamma secretase: has progress moved up a Notch? - Annals of  Oncology
Targeting gamma secretase: has progress moved up a Notch? - Annals of Oncology

The γ-secretase inhibitors used in clinical trial for the treatment of... |  Download Scientific Diagram
The γ-secretase inhibitors used in clinical trial for the treatment of... | Download Scientific Diagram

Pharmaceuticals | Free Full-Text | BACE-1 and γ-Secretase as Therapeutic  Targets for Alzheimer's Disease | HTML
Pharmaceuticals | Free Full-Text | BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer's Disease | HTML

PDF) Three cases of apparent Vasogenic Edema (VE) from a phase 2 clinical  trial of the gamma secretase Inhibitor BMS-708163 in patients with  mild-to-moderate AD | Mark Meadowcroft and charles e albright -
PDF) Three cases of apparent Vasogenic Edema (VE) from a phase 2 clinical trial of the gamma secretase Inhibitor BMS-708163 in patients with mild-to-moderate AD | Mark Meadowcroft and charles e albright -

Clinical trials employing γ-secretase inhibitors in the treatment of... |  Download Scientific Diagram
Clinical trials employing γ-secretase inhibitors in the treatment of... | Download Scientific Diagram

γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and  functionally distinct | EMBO Molecular Medicine
γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct | EMBO Molecular Medicine

γ-secretase inhibitors: Notch so bad | Nature Medicine
γ-secretase inhibitors: Notch so bad | Nature Medicine

γ-secretase inhibitors, DAPT and RO4929097, promote the migration of Human  Glioma Cells via Smad5-downregulated E-cadherin Expression
γ-secretase inhibitors, DAPT and RO4929097, promote the migration of Human Glioma Cells via Smad5-downregulated E-cadherin Expression

Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical  Performance - McCaw - 2021 - The Oncologist - Wiley Online Library
Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance - McCaw - 2021 - The Oncologist - Wiley Online Library

Turning the tide on Alzheimer's disease: modulation of γ-secretase | Cell &  Bioscience | Full Text
Turning the tide on Alzheimer's disease: modulation of γ-secretase | Cell & Bioscience | Full Text

BMS-906024 is an Orally Active γ-Secretase and Notch Inhibitor - Immune  System Research
BMS-906024 is an Orally Active γ-Secretase and Notch Inhibitor - Immune System Research

Amyloid Beta Hypothesis: Attention to β- and γ-Secretase Modulators |  IntechOpen
Amyloid Beta Hypothesis: Attention to β- and γ-Secretase Modulators | IntechOpen

Secretase inhibitors for the treatment of Alzheimer's disease: Long road  ahead - ScienceDirect
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead - ScienceDirect

More Evidence that γ-Secretase Modulators Spare Essential Substrates |  ALZFORUM
More Evidence that γ-Secretase Modulators Spare Essential Substrates | ALZFORUM

Semagacestat – Gamma Secretase Inhibitor for Alzheimer's Disease - Clinical  Trials Arena
Semagacestat – Gamma Secretase Inhibitor for Alzheimer's Disease - Clinical Trials Arena

Gamma-secretase Inhibition | Gamma-secretase Inhibitor Review
Gamma-secretase Inhibition | Gamma-secretase Inhibitor Review

Making the final cut: pathogenic amyloid-β peptide generation by γ-secretase
Making the final cut: pathogenic amyloid-β peptide generation by γ-secretase

A summary of the clinical trials based on passive γ-secretase... | Download  Table
A summary of the clinical trials based on passive γ-secretase... | Download Table

Clinical trials employing γ-secretase inhibitors in the treatment of... |  Download Table
Clinical trials employing γ-secretase inhibitors in the treatment of... | Download Table

Frontiers | DAPT, a γ-Secretase Inhibitor, Suppresses Tumorigenesis, and  Progression of Growth Hormone-Producing Adenomas by Targeting Notch  Signaling | Oncology
Frontiers | DAPT, a γ-Secretase Inhibitor, Suppresses Tumorigenesis, and Progression of Growth Hormone-Producing Adenomas by Targeting Notch Signaling | Oncology

γ-Secretase inhibitors for breast cancer and hepatocellular carcinoma: From  mechanism to treatment - ScienceDirect
γ-Secretase inhibitors for breast cancer and hepatocellular carcinoma: From mechanism to treatment - ScienceDirect

Chemical structure of γ-secretase inhibitors | Download Table
Chemical structure of γ-secretase inhibitors | Download Table